期刊文献+

应用pCMV3-MdmX-RFP表达载体建立H1299^(p53R^(2)13X/MdmX)稳转细胞系

Establishment of the stable H1299^(p53R^(2)13X/MdmX)cell line using pCMV3-MdmX-RFP vector
原文传递
导出
摘要 [目的]探索应用pCMV3-MdmX-RFP表达载体构建H1299^(p53R^(2)13X/MdmX)稳转细胞系。[方法]用KpnⅠ和NotⅠ双酶切后连接,构建pCMV3-MdmX-RFP表达载体并测序。重组质粒转染H1299p53R^(2)13X细胞,用100μg/mL的潮霉素B筛选2 w。将筛选出的细胞无限稀释后分到96孔板中,每孔一个单细胞,并扩增成单细胞群,选出荧光较强的3个细胞克隆(C1、C2和B4)采用Western Blotting和基因组PCR验证。将建立的稳定细胞系命名为H1299^(p53R^(2)13X/MdmX)细胞系,用荧光显微镜观察稳转细胞系的第10代细胞,并用Western Blotting检测MdmX-RFP蛋白的表达情况。G418处理H1299^(p53R^(2)13X/MdmX)细胞后,Western Blotting检测全长p53(full-length p53,FL-p53)和截断的p53(Truncated p53,TR-p53)蛋白表达水平。[结果]测序结果显示,重组质粒pCMV3-MdmX-RFP与数据库中的基因序列相同。稳定细胞系中MdmX-RFP蛋白的高表达,在第10代仍然如此。与对照组相比,用G418处理H1299^(p53R^(2)13X/MdmX)细胞后,FL-p53蛋白水平升高1.6±0.12倍(P<0.05),TR-p53蛋白水平升高3±0.17倍(P<0.01)。[结论]构建的H1299^(p53R^(2)13X/MdmX)稳转细胞系过表达效率高,可直接用于后续实验。 [Objective]To construct a stable H1299~(p53R^(2)13X/MdmX)cell line using pCMV3-MdmX-RFP vector.[Method]Constructed and sequenced the expression vector for pCMV3-MdmX-RFP by double digestion with KpnⅠand NotⅠ,and then linked.The recombinant plasmid pCMV3-MdmX-RFP was transfected into H1299~(p53R^(2)13X)cells,and screened with 100μg/mL of hygromycin B for a fortnight.The screened cells were divided by infinite dilution into 96-well plates,one single cell per well,and expanded into single-cell colonies,and the three cell clones with stronger fluoresce(C1,C2 and B4)was selected for validation by Western Blotting and genome PCR.The established stable cell line was named H1299~(p53R^(2)13X/MdmX)cell line,and the 10th generation cells of the stable cell line was visualized with fluorescent microscope,and the expression of MdmX-RFP protein was confirmed by Western Blotting.The inducible expression level of full-length p53(FL-p53)and Truncated p53(TR-p53)protein was confirmed by Western Blotting after the H1299~(p53R^(2)13X/MdmX)cells were treated with G418.[Result]The sequencing results showed that the recombinant plasmid pCMV3-MdmX-RFP was identical to the gene sequence in the database.The high expression of MdmX-RFP protein in the stable cell line remained so in the tenth generation.Compared with control group,the FL-p53 was elevated 1.6±0.12 times(P<0.05)and the TR-p53 was elevated 3.0±0.17 times(P<0.01)protein expression was increased after treatment of H1299~(p53R^(2)13X/MdmX)cells with G418.[Conclusion]High overexpression efficiency of the constructed H1299~(p53R^(2)13X/MdmX)stable-transformation cell line,which can be used in subsequent experiments.
作者 周婷 李丹 王芮 宋士奎 柯志强 苏正定 ZHOU Ting;LI Dan;WANG Rui;SONG Shikui;KE Zhiqiang;SU Zhengding(Cooperative Innovation Center of Industrial Fermentation(Ministry of Education&Hubei Province),Hubei University of Technology,Wuhan 430068;Department of Neonatology,Xianning Central hospital/First Affiliated Hospital of Hubei University of Science and Technology,Wuhan 437100;Hubei Key Laboratory of Diabetes and Angiopathy,Xianning Medical College,Hubei University of Science and Technology,Xianning 437100;Hubei Goto Biopharm Co.,Ltd.,Yicheng 441400,China)
出处 《生物技术》 CAS 2023年第6期683-688,696,共7页 Biotechnology
基金 湖北省教育厅科学研究计划指导性项目(B2021224)。
关键词 H1299 P53 MDMX G418 潮霉素B 稳转细胞系 H1299 p53 MdmX G418 hygromycin B stable cell line
  • 相关文献

参考文献3

二级参考文献56

  • 1Wang X,Jiang X.Mdm2 and mdmx partner to regulate p53.FEBS Letters,2012,586(10):1390-1396.
  • 2Phillips A,Teunisse A,Lam S,et al.Hdmx-l is expressed from a functional p53-responsive promoter in the first intron of the hdmx gene and participates in an autoregulatory feedback loop to control p53 activity.The Journal of Biological Chemistry,2010,285(38):29111-29127.
  • 3Jacob A G,Singh R K,Comiskey D F Jr,et al.Stress-induced alternative splice forms of mdm2 and mdmx modulate the p53-pathway in distinct ways.Plo S One,2014,9(8):e104444.
  • 4Jiang L,Kon N,Li T Y,et al.Ferroptosis as a p53-mediated activity during tumour suppression.Nature,2015,520(7545):57-62.
  • 5Wade M,Li Y C,Wahl G M.Mdm2,mdmx and p53 in oncogenesis and cancer therapy.Nature Reviews Cancer,2013,13(2):83-96.
  • 6Hong B,van den Heuvel A P,Prabhu V V,et al.Targeting tumor suppressor p53 for cancer therapy:Strategies,challenges and opportunities.Current drug targets,2014,15(1):80-89.
  • 7Lane D,Levine A.P53 research:The past thirty years and the next thirty years.Cold Spring Harbor Perspectives in Biology,2010,2(12):a000893.
  • 8Muller P A,Vousden K H.Mutant p53 in cancer:New functions and therapeutic opportunities.Cancer cell,2014,25(3):304-317.
  • 9Wade M,Wang Y V,Wahl G M.The p53 orchestra:Mdm2 and mdmx set the tone.Trends in Cell Biology,2010,20:299-309.
  • 10Berberich S J.Mdm2 and mdmx involvement in human cancer.Sub-cellular biochemistry,2014,85:263-280.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部